Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Innovative Biologics (United States)
h-index: 22
Total citations: 1,499
Total papers: 100
Recent papers from Innovative Biologics (United States)
The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity
Cancer Research · 2026
Phase IB trial of the BMI-1 inhibitor unesbulin plus neoadjuvant paclitaxel-carboplatin in advanced ovarian cancer
Journal of Ovarian Research · 2026
Terminus-specific antibody development and bioanalytical assay validation to quantify active DR10624 in pharmacokinetic studies
Frontiers in Pharmacology · 2026
B32-36 IBI3002, A First-in-class Anti-IL-4RΑ/TSLP Bispecific Antibody in Patients With Mild-To-Moderate Asthma: A Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase Ib Study
American Journal of Respiratory and Critical Care Medicine · 2026
Two‐Stage Double‐Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical Region
Statistics in Medicine · 2026
Abstract Number: Esoc2026a447 Efficacy and Safety of Tafolecimab in Patients With Cerebrovascular Disease and Hypercholesterolemia: A Post-Hoc Analysis of Pooled Data From Three Phase 3 Trials
European Stroke Journal · 2026
Understanding the epidemiological trends and economic impact of dengue in Indonesia: A systematic literature review
IJID Regions · 2026
The efficacy of tafolecimab in lipoprotein(a) reductions in hypercholesterolaemic patients: a pooled analysis of three phase 3 trials
European Heart Journal · 2025
Approaching a 0% False Positive Rate for PFAS Determination Leveraging Only MS1 Data
Environmental Science & Technology · 2026
DOP058Efficacy and safety of picankibart in patients with moderately to severely active ulcerative colitis: a randomised, double-blind, placebo-controlled phase 2 trial
Journal of Crohn s and Colitis · 2026
Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study
BMC Medicine · 2026
Effect of early prophylactic heparin use on prognosis in critically ill patients with acute pancreatitis: a retrospective cohort study
Scientific Reports · 2025
Therapeutic potential of stem cell-derived exosomes in hair regeneration: A systematic review
World Journal of Stem Cells · 2025
Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRASG12C inhibitor-naïve Chinese patients with KRASG12C-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies
Signal Transduction and Targeted Therapy · 2025
Water Mobility and Clustering in Lyophilized Human Serum Albumin
Molecular Pharmaceutics · 2025
FluoroMatch IM: An Interactive Software for PFAS Analysis by Ion Mobility Spectrometry
Environmental Science & Technology · 2025
Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence
Pain and Therapy · 2025
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
Med · 2025
Autologous Peripheral Blood-Derived Orthobiologics for the Management of Shoulder Disorders: A Review of Current Clinical Evidence
Pain and Therapy · 2024
Platelet Lysate and Osteoarthritis of the Knee: A Review of Current Clinical Evidence
Pain and Therapy · 2024